326 related articles for article (PubMed ID: 10612504)
1. Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost.
Stewart WC; Day DG; Sharpe ED; Dubiner HB; Holmes KT; Stewart JA
Am J Ophthalmol; 1999 Dec; 128(6):692-6. PubMed ID: 10612504
[TBL] [Abstract][Full Text] [Related]
2. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.
Konstas AG; Maltezos AC; Gandi S; Hudgins AC; Stewart WC
Am J Ophthalmol; 1999 Jul; 128(1):15-20. PubMed ID: 10482089
[TBL] [Abstract][Full Text] [Related]
4. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.
Schenker HI; Silver LH
Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287
[TBL] [Abstract][Full Text] [Related]
5. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
Stewart WC; Leland TM; Cate EA; Stewart JA
J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
[TBL] [Abstract][Full Text] [Related]
7. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study.
Mishima HK; Masuda K; Kitazawa Y; Azuma I; Araie M
Arch Ophthalmol; 1996 Aug; 114(8):929-32. PubMed ID: 8694726
[TBL] [Abstract][Full Text] [Related]
8. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol.
Konstas AG; Nakos E; Tersis I; Lallos NA; Leech JN; Stewart WC
Am J Ophthalmol; 2002 Jun; 133(6):753-7. PubMed ID: 12036665
[TBL] [Abstract][Full Text] [Related]
9. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.
Alm A; Stjernschantz J
Ophthalmology; 1995 Dec; 102(12):1743-52. PubMed ID: 9098273
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
García Sanchez J
Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost: experience of 2-year treatment in Scandinavia.
Alm A; Widengård I
Acta Ophthalmol Scand; 2000 Feb; 78(1):71-6. PubMed ID: 10726794
[TBL] [Abstract][Full Text] [Related]
12. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.
Netland PA; Landry T; Sullivan EK; Andrew R; Silver L; Weiner A; Mallick S; Dickerson J; Bergamini MV; Robertson SM; Davis AA;
Am J Ophthalmol; 2001 Oct; 132(4):472-84. PubMed ID: 11589866
[TBL] [Abstract][Full Text] [Related]
13. Latanoprost and timolol combination therapy vs monotherapy: one-year randomized trial.
Higginbotham EJ; Feldman R; Stiles M; Dubiner H;
Arch Ophthalmol; 2002 Jul; 120(7):915-22. PubMed ID: 12096962
[TBL] [Abstract][Full Text] [Related]
14. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.
Watson P; Stjernschantz J
Ophthalmology; 1996 Jan; 103(1):126-37. PubMed ID: 8628543
[TBL] [Abstract][Full Text] [Related]
15. A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension.
Friström B
Acta Ophthalmol Scand; 1996 Apr; 74(2):140-4. PubMed ID: 8739678
[TBL] [Abstract][Full Text] [Related]
16. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group.
Camras CB
Ophthalmology; 1996 Jan; 103(1):138-47. PubMed ID: 8628544
[TBL] [Abstract][Full Text] [Related]
17. Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension.
Harasymowycz P; Hutnik CM; Nicolela M; Stewart WC
Can J Ophthalmol; 2007 Feb; 42(1):75-81. PubMed ID: 17361245
[TBL] [Abstract][Full Text] [Related]
18. A 12 week study comparing the fixed combination of latanoprost and timolol with the concomitant use of the individual components in patients with open angle glaucoma and ocular hypertension.
Diestelhorst M; Larsson LI;
Br J Ophthalmol; 2004 Feb; 88(2):199-203. PubMed ID: 14736774
[TBL] [Abstract][Full Text] [Related]
19. Peak pressures: crossover study of timolol and latanoprost.
Sihota R; Saxena R; Agarwal HC; Pandey RM; Gulati V
Eur J Ophthalmol; 2003 Jul; 13(6):546-52. PubMed ID: 12948313
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study.
Shedden A; Laurence J; Tipping R;
Clin Ther; 2001 Mar; 23(3):440-50. PubMed ID: 11318078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
